Cytori Announces Presentation at Biotech Showcase™ on January 8th

  Cytori Announces Presentation at Biotech Showcase™ on January 8th

Biotech Showcase 2013

Business Wire

SAN DIEGO -- January 4, 2013

Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate
presentation at the Biotech Showcase™ at 11:30 AM PT (2:30 PM ET) on Tuesday,
January 8. The presentation will be held in the Powell Room of the Parc 55
Wyndham Hotel in San Francisco.

The presentation webcast may be accessed on the "Webcasts" page of the
Investor Relations section of the Company's website. The webcast can be
accessed live and will be available for replay approximately one hour after
the presentation on the Company's website.

In addition, Cytori’s CEO Chris Calhoun will be participating on the Alliance
for Regenerative Medicine’s (ARM) State of the Industry panel. The panel
discussion will be filmed and will be made available at a later date on the
ARM website. The details are as follows:

Biotech Showcase™ 2013: ARM State of the Industry Briefing

Date:       January 8, 2013
Time:         8:00 – 10:00 AM PT
Location:     Parc 55 Wyndham, 55 Cyril Magnin Street, San Francisco, CA
              Level 2 – Divisadero Room

About Biotech Showcase™:

Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech
Showcase is an investor and partnering conference devoted to providing private
and public biotechnology and life sciences companies an opportunity to present
to, and meet with, investors and pharmaceutical executives during the course
of one of the industry’s largest annual healthcare investor conferences. Now
in its fifth year, Biotech Showcase is expected to attract upwards of 1,500

About Cytori

Cytori is a leader in cell therapy, providing patients and physicians around
the world with medical technologies that harness the potential of adult
regenerative cells from adipose tissue. The Celution® System family of medical
devices and instruments is being sold into the European and Asian cosmetic and
reconstructive surgery markets but is not yet available in the United States.
Our StemSource® product line is sold globally for cell banking and research
applications. Our PureGraft® products are available in North America and
Europe for fat grafting procedures.


Cytori Therapeutics, Inc.
Megan McCormick
Press spacebar to pause and continue. Press esc to stop.